Research graph
References from Bilateral Vaso-Occlusive Retinopathy Unmasking Primary Antiphospholipid Syndrome in a Child. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1111/j.1538-7836.2006.01753.x
10.1111/j.1538-7836.2006.01753.x · External reference
10.1007/s11926-020-00976-7
10.1007/s11926-020-00976-7 · External reference
10.1186/s12969-022-00677-8
10.1186/s12969-022-00677-8 · External reference
Ocular manifestations of antiphospholipid syndrome
10.1136/bjo.2010.182857 · 2011 · External reference
Catastrophic antiphospholipid syndrome presenting with neuroretinitis and vaso-occlusive retinopathy
10.1186/s12886-020-01755-9 · 2020 · External reference
Retinal vein and artery occlusion as the first manifestation of primary antiphospholipid syndrome in a pediatric patient
2024 · External reference
10.1016/j.ajo.2005.03.057
10.1016/j.ajo.2005.03.057 · External reference
10.1002/art.40930
10.1002/art.40930 · External reference
10.1097/icb.0000000000000161
10.1097/icb.0000000000000161 · External reference
10.1186/1471-2431-14-116
10.1186/1471-2431-14-116 · External reference
10.1177/24741264231153614
10.1177/24741264231153614 · External reference
10.1016/s0181-5512(05)81087-3
10.1016/s0181-5512(05)81087-3 · External reference
10.1038/nrrheum.2011.52
10.1038/nrrheum.2011.52 · External reference
10.3389/fimmu.2019.00449
10.3389/fimmu.2019.00449 · External reference
10.3390/diagnostics15070871
10.3390/diagnostics15070871 · External reference
Plasmapheresis in catastrophic antiphospholipid syndrome
2020 · External reference
10.1164/rccm.202009-3489le
10.1164/rccm.202009-3489le · External reference
10.3390/ijms24021331
10.3390/ijms24021331 · External reference
10.1002/art.40930
10.1002/art.40930 · ExternalCitation · doi-reference
10.1007/s11926-020-00976-7
10.1007/s11926-020-00976-7 · ExternalCitation · doi-reference
10.1016/j.ajo.2005.03.057
10.1016/j.ajo.2005.03.057 · ExternalCitation · doi-reference
10.1016/s0181-5512(05)81087-3
10.1016/s0181-5512(05)81087-3 · ExternalCitation · doi-reference
10.1038/nrrheum.2011.52
10.1038/nrrheum.2011.52 · ExternalCitation · doi-reference
10.1097/icb.0000000000000161
10.1097/icb.0000000000000161 · ExternalCitation · doi-reference
10.1111/j.1538-7836.2006.01753.x
10.1111/j.1538-7836.2006.01753.x · ExternalCitation · doi-reference
Ocular manifestations of antiphospholipid syndrome
10.1136/bjo.2010.182857 · ExternalCitation · doi-reference
10.1164/rccm.202009-3489le
10.1164/rccm.202009-3489le · ExternalCitation · doi-reference
10.1177/24741264231153614
10.1177/24741264231153614 · ExternalCitation · doi-reference
10.1186/1471-2431-14-116
10.1186/1471-2431-14-116 · ExternalCitation · doi-reference
Catastrophic antiphospholipid syndrome presenting with neuroretinitis and vaso-occlusive retinopathy
10.1186/s12886-020-01755-9 · ExternalCitation · doi-reference
10.1186/s12969-022-00677-8
10.1186/s12969-022-00677-8 · ExternalCitation · doi-reference
10.3389/fimmu.2019.00449
10.3389/fimmu.2019.00449 · ExternalCitation · doi-reference
10.3390/diagnostics15070871
10.3390/diagnostics15070871 · ExternalCitation · doi-reference
10.3390/ijms24021331
10.3390/ijms24021331 · ExternalCitation · doi-reference
